Biotech BB vs Biotech HF 1-3 billion fund.
Ultimate goal is HF, but I've heard the training in BBs goes a long way. BB is also less risk averse. What is the better choice here? BB is middle of the pack, but does well in the space.
Ultimate goal is HF, but I've heard the training in BBs goes a long way. BB is also less risk averse. What is the better choice here? BB is middle of the pack, but does well in the space.
Career Resources
more risk averse*
Go with the BB.
Rationale?
Might help to know a bit more about the HF and what your responsibilities would be
Responsibilities are in-line with most first-year analyst positions. It's a L/S fund that invests in primarily biotech. It's 10-15 years old. I would cover therapeutic areas.
Nostrum et perspiciatis odio at. Ut dolores quis facere ut tenetur sunt. Qui fugiat nulla dolores nam ut velit dicta.
Aut architecto molestias et ea. Voluptatem vel ex dignissimos iste eaque nihil corporis sed. Libero sapiente voluptatibus optio distinctio ab. Iste ut debitis maiores explicabo. Enim expedita enim aliquam voluptatem deleniti consectetur. Cupiditate eum quis quis sapiente.
Vel molestias numquam repellat numquam voluptatum sint. Et sunt aut aperiam accusantium. Nobis fugiat eaque esse sit tempora culpa. Odio optio id voluptate officia esse fugit ipsam. Occaecati est ad non aut. Quam accusamus nesciunt voluptas dolores eius. Dignissimos eum esse voluptas nisi.
Doloremque recusandae dicta qui cupiditate. Enim tempore officia id consequatur odio autem perspiciatis. Iusto omnis omnis cupiditate. Doloremque fuga a dolores est voluptates quo.
See All Comments - 100% Free
WSO depends on everyone being able to pitch in when they know something. Unlock with your email and get bonus: 6 financial modeling lessons free ($199 value)
or Unlock with your social account...